PM Modi assures 'India's vaccine production will help the world fight COVID' at UNGA

Touting India's large vaccine production, PM Narendra Modi on Saturday, assured world that nation will help in mass production of Coronavirus (COVID-19) vaccine, while virtually dressing United Nations' General Assembly. Briefing about India's own vaccine trials, he said that India was progressing with phase-3 human trials. PM Modi also spoke about India's UNSC permanent seat, Atmanirbhar Bharat scheme, his government's various schemes, and need for reforming UN as an institution.

PM Modi's UNGA speech: From UN reforms & expanded role for India to vaccine potential

PM Modi touts India's vaccine production capacity

 "In times of challenging times of pandemic, India's pharma industry has sent 150 countries necessary medicines. I want to assure world that India's vaccine production will help whole world in fighting crisis. We are moving ahe with phase 3 of clinical trials," he said.

PM Modi lashes out at UN over India's permanent seat, says "How long must we wait?"

PM Modi: 'How long should India wait?'

In his virtual dress, PM Modi also questioned UN's hesitancy in making India a permanent member. Lashing out at UN, he said that India's 1.3 billion people awaited for changes to happen in real world, with unparalleled trust in UN. On June 17, India was elected as a n-permanent member to United Nations Security Council (UNSC) for eighth-time and will begin its term in January 2021.

" trust India has in UN is unparalleled. But Indians are waiting for reforms in UN. y are concerned if reform process will reach logical end? How long will India be kept away from decision-making in UN? How long will country have to wait for changes happening in real world? India aspires to be in an expanded role in UN," he said.

Lok Sabha updated on COVID vaccine trials

Recently on September 18, Ministry of Health informed Lok Sabha of vaccine trial procedure, via a written reply regarding sts of vaccine research, as approved by Indian Council of Medical Research (ICMR). Four COVID-19 vaccine candidates are currently in various human trial phases in India -Bharat Biotech - ICMR (BBV 152), Cila-Zydus (ZyCOV-D), Serum-ICMR & Oxford-AstraZeneca (ChOx1-S) and Serum-ICMR & vavax. India is second worst-hit nation after US with over 59 lakh cases.

Centre briefs Lok Sabha on COVID-19 vaccine trials in India; 7 manufacturers shortlisted

Apart from vaccine trials, India is in talks with Russia about its COVID-19 vaccine - 'Sputnik -V', with Dr. Reddy's lab selected as manufacturers to provide 100 million doses in India. Central Drugs Standard Control Organisation (CDSCO) has listed 7 Indian manufacturers permitted for COVID-19 vaccine manufacturing - Serum Institute of India (SII), Cila Healthcare, Bharat Biotech, Biological E, Reliance Life Sciences, Aurbindo Pharma, and Genva Biopharmaceuticals. While India hopes to get a vaccine rey by 2020 end, Centre is reying a blueprint for mass production and vaccine distribution.

Coronavirus LIVE Updates: India's tally crosses 59 lakhs; 48,49,585 recover so far